North America Oligonucleotide Synthesis Market to Reach US$ $ 1,541.03 Mn at a CAGR of 11.2% in 2027 | The Insight Partners

North America Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)

Publication Month: Oct 2019 | Report Code: TIPRE00007127 | No. of Pages: 134 | Category: Biotechnology | Status: Published

The North America Oligonucleotide Synthesis market is expected to reach US$ $ 1,541.03 Mn in 2027 from US$ 609.90 Mn in 2018. The market is estimated to grow with a CAGR of 11.2% from 2019-2027.

 

The growth of the market is driven by the factors such as, rising investments in the development of pharmaceutical and biotechnology companies, funds from government bodies as well as rise in the number of market players and their focus in the oligonucleotide synthesis market are likely to boost the growth of the oligonucleotide synthesis in the region during the forecast period.

 

Oligonucleotides are used in many biological applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA. Oligonucleotides have variety of uses in diseases diagnosis, biotechnology research, therapeutics, forensic, drug discovery, etc. Synthetic oligonucleotides are widely used in the human genetic disease diagnosis. Oligonucleotide probes are used to detect single base pair changes within human genome. For instance, sickle cell anemia which is caused by a transversion (A^T) within β-globin gene can be analyzed with labeled oligonucleotides. Under stringent hybridization conditions, it is possible to detect whether one or two of family's alleles contain the mutant gene.

Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).

Oligonucleotides also enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. For instance, Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.

There have been clinical trials in Canada during the recent years, which are expected to promote the growth of oligonucleotide synthesis market. For instance, as per press release during January 2019, a phase 3 trial has been enrolling adults affected with Huntington’s disease across the United States and Canada to test the potential of the investigational therapy RG6042. RG6042, initially known as IONIS-HTTRx, is an analytical antisense oligonucleotide treatment that was earlier developed by Ionis Pharmaceuticals and later on had been acquired by Roche. It is designed to target and destroy different forms of mutant huntingtin protein (mHTT), which is the main cause of the Huntington’s disease. The trial is being expected to be conducted across six sites, across five Canadian provinces

                                                         

US is expected to lead the market in the North America region owing to increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of gene synthesis based end products such as precision medicine and other therapeutics. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

 

Exhibit: Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

 

 

NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION

 

By Product

  • Synthesized Oligonucleotides
    • Primers
    • Probes
    • Large-Scale Synthesis
    • Others
  • Reagents
    • Equipment

 

By Application

  • Research
  • Diagnostics
  • Therapeutics

 

By End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

 

By Geography

  • North America
    • US
    • Canada
    • Mexico

Company Profiles

  • Thermo Fisher Scientific Inc.
  • GenScript
  • Molecular Assemblies
  • Twist Biosciences
  • Evonetix
  • DNA Script
  • Nuclera Nucleics
  • Camena Bioscience
  • Synthomics
  • Ansa Biotechnologies

1.              Introduction

1.1       Scope Of The Study

1.2       The Insight Partners Research Report Guidance

2.              North America Oligonucleotide Synthesis Market – Key Takeaways

3.              North America Oligonucleotide Synthesis Market – Market Landscape

3.1       Overview

3.2       Market Segmentation

3.2.1       North America Oligonucleotide Synthesis Market – By Product

3.2.2       North America Oligonucleotide Synthesis Market – By Application

3.2.3       North America Oligonucleotide Synthesis Market – By End User

3.2.4       North America Oligonucleotide Synthesis Market – By Country

3.3       PEST Analysis

3.3.1       North America – PEST Analysis

4.              North America Oligonucleotide Synthesis Market - Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Rising adoption of Synthesized Oligonucleotides to Treat Medical Conditions

4.1.2       Technological Advancements in Synthetic Biology

4.1.3       Growing Investments by Private Players in Synthetic Biology

4.2       Key Market Restraints

4.2.1       Renewed Policies for Biotechnology Industry

4.2.2       Biotechnology Lacks Skilled Professionals

4.3       Key Market Opportunities

4.3.1       Collaborations — The Future of Innovation

4.4       Future Trends

4.4.1       New Product Developments in Synthetic Biology

4.5       Impact Analysis

5.              Oligonucleotide Synthesis – North America Analysis

5.1       North America Oligonucleotide Synthesis Market Revenue Forecasts And Analysis

5.2       Market Positioning

5.3       Performance of Key Players

5.3.1       Thermo Fisher Scientific Inc.

5.3.2       GenScript

5.4       Expert Opinions

6.              North America Oligonucleotide Synthesis Market Analysis –By Product

6.1       Overview

6.2       North America Oligonucleotide Synthesis Market, By Product, 2018 & 2027 (%)

6.3       Synthesized Oligonucleotides Market

6.3.1       Overview

6.3.2       North America Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.3       Primers Market

6.3.3.1    Overview

6.3.3.2    North America Primers Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4       Probes Market

6.3.4.1    Overview

6.3.4.1.1    North America Probes Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4.2    Large-Scale Synthesis Oligonucleotides Market

6.3.4.2.1    Overview

6.3.4.2.2    North America Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4.3    Others Market

6.3.4.3.1    Overview

6.3.4.3.2    North America Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.4       Reagents Market

6.4.1       Overview

6.4.2       North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

6.5       Equipment Market

6.5.1       Overview

6.5.2       North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

7.              North America Oligonucleotide Synthesis Market Analysis –By Application

7.1       Overview

7.2       North America Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)

7.3       Research Market

7.3.1       Overview

7.3.2       North America Research Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Diagnostics Market

7.4.1       Overview

7.4.2       North America Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Therapeutics Market

7.5.1       Overview

7.5.2       North America Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.              North America Oligonucleotide Synthesis Market Analysis –By End User

8.1       Overview

8.2       North America Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)

8.3       Academic Research Institutes Market

8.3.1       Overview

8.3.2       North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Diagnostic Laboratories Market

8.4.1       Overview

8.4.2       North America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Pharmaceutical & Biotechnology Companies Market

8.5.1       Overview

8.5.2       North America Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

8.6       Other End Users Market

8.6.1       Overview

8.6.2       North America Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

9.              North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027

9.1       Overview

9.1.1       North America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2       North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.2.1    North America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.3       North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.4       North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5       North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

9.1.6       US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1    US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2    US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6.2.1    US Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.6.3    US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.6.4    US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7       Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2    Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.7.2.1    Canada Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.3    Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.7.4    Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8       Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1    Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2    Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.8.2.1    Mexico Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.8.3    Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.8.4    Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.           Oligonucleotide Synthesis Market –Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies Done By the Companies in the Market, (%)

10.4    Organic Developments

10.4.1    Overview

10.5    Inorganic Developments

10.5.1    Overview

11.           Oligonucleotide Synthesis Market–Key Company Profiles

11.1    Thermo Fisher Scientific Inc.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    GenScript

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Synthomics, Inc.

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Ansa Biotechnologies, Inc.

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Overview

11.4.4    Product portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Iridia, Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Helixworks

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial overview

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Keasling Lab

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Molecular Assemblies

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Overview

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    Twist Bioscience

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Product portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Evonetix

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11  DNA Script

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Financial overview

11.11.4 Product Portfolio

11.11.5 SWOT Analysis

11.11.6 Key Developments

11.12  Nuclera Nucleics Ltd.

11.12.1 Key Facts

11.12.2 Business Description

11.12.3 Financial Overview

11.12.4 Product Portfolio

11.12.5 SWOT Analysis

11.12.6 Key Developments

11.13  Camena Bio

11.13.1 Key Facts

11.13.2 Business Description

11.13.3 Financial Overview

11.13.4 Product Portfolio

11.13.5 SWOT Analysis

11.13.6 Key Developments

12.           Appendix

12.1    About The Insight Partners

12.2    Glossary Of Terms

12.3    Methodology

12.3.1    Coverage

12.3.2    Secondary Research

12.3.3    Primary Research


LIST OF TABLES

Table 1.            North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 2.            North America Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type  (US$ Mn)

Table 3.            North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 4.            North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 5.            US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 6.            US Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 7.            US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 8.            US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 9.            Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 10.         Canada Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 11.         Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 12.         Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 13.         Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 14.         Mexico Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 15.         Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 16.         Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 17.         Organic Developments Done By Companies

Table 18.         Inorganic Developments Done By Companies

Table 19.         Glossary Of Terms, Oligonucleotide Synthesis Market


LIST OF FIGURES

Figure 1.          US Oligonucleotide Synthesis Market, Revenue (US$ Bn), By 2018 & 2027

Figure 2.          North America Synthesized Oligonucleotides Market By Product, Market Share (%), 2018

Figure 3.          Global Oligonucleotide Synthesis Market By Application, Market Share (%), 2018

Figure 4.          Global Oligonucleotide Synthesis Market By End User, Market Share (%), 2018

Figure 5.          Oligonucleotide Synthesis Market Segmentation

Figure 6.          North America PEST Analysis

Figure 7.          Oligonucleotide Synthesis Market Impact Analysis Of Driver And Restraints

Figure 8.          North America Oligonucleotide Synthesis Market – Revenue Forecasts And Analysis – 2017- 2027

Figure 9.          North America Oligonucleotide Synthesis Market By Product, 2018 & 2027 (%)

Figure 10.       North America Synthesized Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.       North America Primers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       North America Probes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       North America Large-Scale Synthesis Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       North America Reagents Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Oligonucleotide Synthesis Market By Application, 2018 & 2027 (%)

Figure 18.       North America Research Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       North America Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       North America Therapeutics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       North America Oligonucleotide Synthesis Market By End User, 2018 & 2027 (%)

Figure 22.       North America Academic Research Institutes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       North America Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       North America Pharmaceutical & Biotechnology Companies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       North America Other End Users Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       North America Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Country (%)

Figure 28.       US Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Canada Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30.       Mexico Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 31.       Comparative Company Analysis

Figure 32.       Growth Strategies Done By the Companies in the Market, (%)

 

The List of Companies

  1. Thermo Fisher Scientific Inc.
  2. GenScript
  3. Molecular Assemblies
  4. Twist Biosciences
  5. Evonetix
  6. DNA Script
  7. Nuclera Nucleics
  8. Camena Bioscience
  9. Synthomics
  10. Ansa Biotechnologies

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America oligonucleotide synthesis market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.